Skip to main content
. 2019 May 9;9(6):e01247. doi: 10.1002/brb3.1247

Table 2.

Five‐year prevalence of FoG in DLB and PD patients

  FoG+ FoG‐
T0 DLB 13 (68.4%) 6 (31.6%)
PD 2 (10.5%) 17 (89.5%)
  p value 0.0006  
T1 DLB 16 (84.2%) 3 (15.8%)
PD 2 (10.5%) 17 (89.5%)
  p value 0.0001  
T2 DLB 16 (84.2%) 3 (15.8%)
PD 5 (26.3%) 14 (73.7%)
  p value 0.0008  
T3 DLB 17 (89.5%) 2 (10.5%)
PD 7 (36.8%) 12 (63.2%)
  p value 0.0019  
T4 DLB 17 (89.5%) 2 (10.5%)
PD 8 (42.1%) 11 (57.9%)
  p value 0.0051  
T5 DLB 18 (94.7%) 1 (5.3%)
PD 9 (47.3%) 10 (52.6%)
  p value 0.003